Fujian Cosunter Pharmaceutical Co Ltd (300436) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.055x

Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.74 Million ≈ $-3.77 Million USD) by net assets (CN¥468.48 Million ≈ $68.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Fujian Cosunter Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Fujian Cosunter Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Fujian Cosunter Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Neptune Insurance Holdings Inc. NYSE:NP	-0.056x
Nuode Investment Co Ltd SHG:600110	0.013x
CETC Energy Joint Stock Co Ltd SHG:600877	-0.019x
Shanxi Securities Co Ltd SHE:002500	0.284x
Piramal Enterprises Limited NSE:PEL	-0.299x
Xiamen Bank Co Ltd SHG:601187	0.071x
Clas Ohlson AB (publ) ST:CLAS-B	0.515x
AIMA Technology Group Co Ltd SHG:603529	0.294x

Annual Cash Flow Conversion Efficiency for Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Fujian Cosunter Pharmaceutical Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥346.30 Million ≈ $50.67 Million	CN¥-35.05 Million ≈ $-5.13 Million	-0.101x	-293.94%
2024-12-31	CN¥396.78 Million ≈ $58.06 Million	CN¥20.71 Million ≈ $3.03 Million	0.052x	+117.02%
2023-12-31	CN¥569.24 Million ≈ $83.30 Million	CN¥-174.60 Million ≈ $-25.55 Million	-0.307x	-144.91%
2022-12-31	CN¥955.62 Million ≈ $139.84 Million	CN¥-119.68 Million ≈ $-17.51 Million	-0.125x	-640.11%
2021-12-31	CN¥1.05 Billion ≈ $153.63 Million	CN¥-17.76 Million ≈ $-2.60 Million	-0.017x	-163.14%
2020-12-31	CN¥581.99 Million ≈ $85.16 Million	CN¥15.60 Million ≈ $2.28 Million	0.027x	-54.76%
2019-12-31	CN¥573.74 Million ≈ $83.96 Million	CN¥33.99 Million ≈ $4.97 Million	0.059x	+204.40%
2018-12-31	CN¥562.35 Million ≈ $82.29 Million	CN¥10.94 Million ≈ $1.60 Million	0.019x	-84.97%
2017-12-31	CN¥552.05 Million ≈ $80.78 Million	CN¥71.47 Million ≈ $10.46 Million	0.129x	-3.16%
2016-12-31	CN¥552.36 Million ≈ $80.83 Million	CN¥73.84 Million ≈ $10.81 Million	0.134x	-37.82%
2015-12-31	CN¥519.20 Million ≈ $75.97 Million	CN¥111.63 Million ≈ $16.33 Million	0.215x	-68.49%
2014-12-31	CN¥156.87 Million ≈ $22.96 Million	CN¥107.04 Million ≈ $15.66 Million	0.682x	+47.49%
2013-12-31	CN¥143.10 Million ≈ $20.94 Million	CN¥66.20 Million ≈ $9.69 Million	0.463x	+19.69%
2012-12-31	CN¥108.59 Million ≈ $15.89 Million	CN¥41.97 Million ≈ $6.14 Million	0.387x	-52.42%
2011-12-31	CN¥65.43 Million ≈ $9.58 Million	CN¥53.15 Million ≈ $7.78 Million	0.812x	--

About Fujian Cosunter Pharmaceutical Co Ltd

SHE:300436 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.74 Billion

CN¥18.71 Billion CNY

Market Cap Rank

#5338 Global

#1047 in China

Share Price

CN¥117.50

Change (1 day)

-2.87%

52-Week Range

CN¥28.25 - CN¥172.22

All Time High

CN¥172.22